Cite
HARVARD Citation
Khare, P. et al. (n.d.). 149 GEN-011: An ATLASTM-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches. Journal for immunotherapy of cancer. p. A90. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khare, P. et al. (n.d.). 149 GEN-011: An ATLASTM-guided peripheral-blood derived neoantigen-specific T cell therapy designed to improve on TIL approaches. Journal for immunotherapy of cancer. p. A90. [Online].